PIK3CA and malignant colon neoplasm: Another drawback is that our current study did not utilize functional assays to investigate potential molecular mechanisms through which aspirin may exert stronger anti-cancer effects on PIK3CA-mutant colon cancer cells than PIK3CA-wild-type cells.